Literature DB >> 28360582

Botulinum Toxin in Migraine Treatment.

Elif Ilgaz Aydinlar1, Pınar Yalinay Dikmen1, Ayşe Sağduyu Kocaman1.   

Abstract

Since botulinum toxin might have a therapeutic effect on pain, many studies investigating the efficiency of botulinum toxin in headache treatment have been done. The most satisfying results were achieved by botulinum toxin type A (BoNT/A) in the treatment of chronic migraine. In this paper, we reviewed the clinical effectiveness of BoNT/A in migraine and included our clinical experience. In our ongoing pilot study, where we have repeated BoNT/A injections every 12 weeks, The difference in the Migraine Disability Assessment (MIDAS) scores between the first and the second injections was 61.1%; and between the first and the 3rd injections was found to be 65.72%.

Entities:  

Keywords:  Botulinum toxin; chronic migraine; headache

Year:  2013        PMID: 28360582      PMCID: PMC5353076          DOI: 10.4274/npa.y7198

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  34 in total

1.  Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

Authors:  M J Welch; J R Purkiss; K A Foster
Journal:  Toxicon       Date:  2000-02       Impact factor: 3.033

Review 2.  Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.

Authors:  Oliver Dolly
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

3.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

Review 4.  Pharmacology and immunology of botulinum neurotoxins.

Authors:  K Roger Aoki
Journal:  Int Ophthalmol Clin       Date:  2005

5.  Botulinum neurotoxin in the treatment of headache disorders.

Authors:  Alexander Mauskop
Journal:  Handb Clin Neurol       Date:  2010

6.  Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors:  Ninan T Mathew; Benjamin M Frishberg; Marek Gawel; Rozalina Dimitrova; John Gibson; Catherine Turkel
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

Review 7.  Treatment of chronic migraine headache with onabotulinumtoxinA.

Authors:  Robert Gerwin
Journal:  Curr Pain Headache Rep       Date:  2011-10

8.  Migraine prophylactic medication usage patterns in The Netherlands.

Authors:  H Rahimtoola; H Buurma; C C Tijssen; H G Leufkens; A C G Egberts
Journal:  Cephalalgia       Date:  2003-05       Impact factor: 6.292

9.  Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Authors:  Marcelo E Bigal; Daniel Serrano; Michael Reed; Richard B Lipton
Journal:  Neurology       Date:  2008-08-19       Impact factor: 9.910

10.  Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Authors:  Sheena K Aurora; Marek Gawel; Jan L Brandes; Suriani Pokta; Amanda M Vandenburgh
Journal:  Headache       Date:  2007-04       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.